Publication:
The expression pattern of members of the EGFR signaling pathway and its relation with the duration of response in metastatic breast cancer (BC) patients (pts) treated with endocrine therapy (ET)

dc.contributor.authorsAtalay, G; Durbecq, V; Larsimont, D; Rouas, G; Di Leo, A; Leroy, JY; Piccart, MJ
dc.date.accessioned2022-03-12T15:58:49Z
dc.date.accessioned2026-01-11T08:06:26Z
dc.date.available2022-03-12T15:58:49Z
dc.date.issued2004
dc.identifier.doidoiWOS:000223512400935
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/224178
dc.identifier.wosWOS:000223512400935
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe expression pattern of members of the EGFR signaling pathway and its relation with the duration of response in metastatic breast cancer (BC) patients (pts) treated with endocrine therapy (ET)
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage236S
oaire.citation.issue14
oaire.citation.startPage236S
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume22

Files